E85 Amyloidosis
E85 is the ICD-10-CM code family for Amyloidosis: 9 codes, all of which can lead a home health claim.
Codes in family
9
Can lead a claim
9
Cannot lead a claim
0
What CMS assigns to E85
All 9 codes group to MMTA - Endocrine. None of the 9 is assigned a comorbidity subgroup. Every code can lead a claim.
Every code in E85
Descriptions are CDC’s FY2027 wording; where CMS’s grouper abbreviates one, its form is shown beneath.
| Code | Description | Primary position | Clinical group | Comorbidity subgroup |
|---|---|---|---|---|
| E85.0 | Non-neuropathic heredofamilial amyloidosis | Can lead a claim | I | None |
| E85.1 | Neuropathic heredofamilial amyloidosis | Can lead a claim | I | None |
| E85.2 | Heredofamilial amyloidosis, unspecified | Can lead a claim | I | None |
| E85.3 | Secondary systemic amyloidosis | Can lead a claim | I | None |
| E85.4 | Organ-limited amyloidosis | Can lead a claim | I | None |
| E85.8 Other amyloidosis | ||||
| E85.81 | Light chain (AL) amyloidosis | Can lead a claim | I | None |
| E85.82 | Wild-type transthyretin-related (ATTR) amyloidosis | Can lead a claim | I | None |
| E85.89 | Other amyloidosis | Can lead a claim | I | None |
| E85.9 | Amyloidosis, unspecified | Can lead a claim | I | None |
Sources: CMS HH PPS Grouper Software (opens in a new tab) v07.2.26, effective 2026-10-01, for the clinical group, comorbidity subgroup, code-first conventions and primary-position flags; CDC NCHS ICD-10-CM FY2027 (opens in a new tab) code descriptions for the family title and code wording. This is the crosswalk Medicare runs a claim through. Grouping also depends on admission source, timing, the OASIS functional items and the rest of the diagnosis list.